 | • レポートコード：GIR201111755 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、血友病A治療薬の世界市場を調査対象にし、血友病A治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他）、用途別分析（クリニック、病院、ASC）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Bayer AG、Dimension Therapeutics Inc、Catalyst Biosciences Inc、BioMarin Pharmaceutical Inc、DBV Technologies SA、Bioverativ Inc、Expression Therapeutics LLC、CSL Ltd、Chugai Pharmaceutical Co Ltd、EpiVax Inc、mAbxience SA、Green Cross Corp、LFB SA、Idogen AB、Immusoft Corp ・メーカー別販売量、売上、市場シェア ・血友病A治療薬の地域別市場分析 ・血友病A治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・血友病A治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・血友病A治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・血友病A治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・血友病A治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・血友病A治療薬の種類別市場規模2015-2020：ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他 ・血友病A治療薬の用途別市場規模2015-2020：クリニック、病院、ASC ・血友病A治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Hemophilia A Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Hemophilia A Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Hemophilia A Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hemophilia A Drug market has been segmented into
ATXF-8117
BAY-1093884
BIVV-001
BS-027125
Concizumab
CSL-689
Others
By Application, Hemophilia A Drug has been segmented into:
Clinic
Hospital
ASCs
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hemophilia A Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hemophilia A Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hemophilia A Drug market.
The report offers in-depth assessment of the growth and other aspects of the Hemophilia A Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Hemophilia A Drug Market Share Analysis
Hemophilia A Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hemophilia A Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hemophilia A Drug sales, revenue and market share for each player covered in this report.
The major players covered in Hemophilia A Drug are:
Bayer AG
Dimension Therapeutics Inc
Catalyst Biosciences Inc
BioMarin Pharmaceutical Inc
DBV Technologies SA
Bioverativ Inc
Expression Therapeutics LLC
CSL Ltd
Chugai Pharmaceutical Co Ltd
EpiVax Inc
mAbxience SA
Green Cross Corp
LFB SA
Idogen AB
Immusoft Corp
Among other players domestic and global, Hemophilia A Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemophilia A Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hemophilia A Drug, with price, sales, revenue and global market share of Hemophilia A Drug in 2018 and 2019.
Chapter 3, the Hemophilia A Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemophilia A Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Hemophilia A Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Hemophilia A Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Hemophilia A Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Hemophilia A Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Hemophilia A Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Overview of Global Hemophilia A Drug Market
1.4.1 Global Hemophilia A Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer AG
2.1.1 Bayer AG Details
2.1.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer AG SWOT Analysis
2.1.4 Bayer AG Product and Services
2.1.5 Bayer AG Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dimension Therapeutics Inc
2.2.1 Dimension Therapeutics Inc Details
2.2.2 Dimension Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dimension Therapeutics Inc SWOT Analysis
2.2.4 Dimension Therapeutics Inc Product and Services
2.2.5 Dimension Therapeutics Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Catalyst Biosciences Inc
2.3.1 Catalyst Biosciences Inc Details
2.3.2 Catalyst Biosciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Catalyst Biosciences Inc SWOT Analysis
2.3.4 Catalyst Biosciences Inc Product and Services
2.3.5 Catalyst Biosciences Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BioMarin Pharmaceutical Inc
2.4.1 BioMarin Pharmaceutical Inc Details
2.4.2 BioMarin Pharmaceutical Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BioMarin Pharmaceutical Inc SWOT Analysis
2.4.4 BioMarin Pharmaceutical Inc Product and Services
2.4.5 BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 DBV Technologies SA
2.5.1 DBV Technologies SA Details
2.5.2 DBV Technologies SA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 DBV Technologies SA SWOT Analysis
2.5.4 DBV Technologies SA Product and Services
2.5.5 DBV Technologies SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bioverativ Inc
2.6.1 Bioverativ Inc Details
2.6.2 Bioverativ Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bioverativ Inc SWOT Analysis
2.6.4 Bioverativ Inc Product and Services
2.6.5 Bioverativ Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Expression Therapeutics LLC
2.7.1 Expression Therapeutics LLC Details
2.7.2 Expression Therapeutics LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Expression Therapeutics LLC SWOT Analysis
2.7.4 Expression Therapeutics LLC Product and Services
2.7.5 Expression Therapeutics LLC Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 CSL Ltd
2.8.1 CSL Ltd Details
2.8.2 CSL Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CSL Ltd SWOT Analysis
2.8.4 CSL Ltd Product and Services
2.8.5 CSL Ltd Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Chugai Pharmaceutical Co Ltd
2.9.1 Chugai Pharmaceutical Co Ltd Details
2.9.2 Chugai Pharmaceutical Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Chugai Pharmaceutical Co Ltd SWOT Analysis
2.9.4 Chugai Pharmaceutical Co Ltd Product and Services
2.9.5 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 EpiVax Inc
2.10.1 EpiVax Inc Details
2.10.2 EpiVax Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 EpiVax Inc SWOT Analysis
2.10.4 EpiVax Inc Product and Services
2.10.5 EpiVax Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 mAbxience SA
2.11.1 mAbxience SA Details
2.11.2 mAbxience SA Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 mAbxience SA SWOT Analysis
2.11.4 mAbxience SA Product and Services
2.11.5 mAbxience SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Green Cross Corp
2.12.1 Green Cross Corp Details
2.12.2 Green Cross Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Green Cross Corp SWOT Analysis
2.12.4 Green Cross Corp Product and Services
2.12.5 Green Cross Corp Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 LFB SA
2.13.1 LFB SA Details
2.13.2 LFB SA Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 LFB SA SWOT Analysis
2.13.4 LFB SA Product and Services
2.13.5 LFB SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Idogen AB
2.14.1 Idogen AB Details
2.14.2 Idogen AB Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Idogen AB SWOT Analysis
2.14.4 Idogen AB Product and Services
2.14.5 Idogen AB Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Immusoft Corp
2.15.1 Immusoft Corp Details
2.15.2 Immusoft Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Immusoft Corp SWOT Analysis
2.15.4 Immusoft Corp Product and Services
2.15.5 Immusoft Corp Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Hemophilia A Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Hemophilia A Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Hemophilia A Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Hemophilia A Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Hemophilia A Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Hemophilia A Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Hemophilia A Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Hemophilia A Drug Sales and Growth Rate (2015-2020)
4.3 Europe Hemophilia A Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Hemophilia A Drug Sales and Growth Rate (2015-2020)
4.5 South America Hemophilia A Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Hemophilia A Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Hemophilia A Drug Sales, Revenue and Market Share by Country
5.1.1 North America Hemophilia A Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Hemophilia A Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Hemophilia A Drug Sales and Growth Rate (2015-2020)
5.3 Canada Hemophilia A Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Hemophilia A Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Hemophilia A Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Hemophilia A Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Hemophilia A Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Hemophilia A Drug Sales and Growth Rate (2015-2020)
6.3 UK Hemophilia A Drug Sales and Growth Rate (2015-2020)
6.4 France Hemophilia A Drug Sales and Growth Rate (2015-2020)
6.5 Russia Hemophilia A Drug Sales and Growth Rate (2015-2020)
6.6 Italy Hemophilia A Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Hemophilia A Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Hemophilia A Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Hemophilia A Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Hemophilia A Drug Sales and Growth Rate (2015-2020)
7.3 Japan Hemophilia A Drug Sales and Growth Rate (2015-2020)
7.4 Korea Hemophilia A Drug Sales and Growth Rate (2015-2020)
7.5 India Hemophilia A Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Hemophilia A Drug Sales and Growth Rate (2015-2020)
7.7 Australia Hemophilia A Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Hemophilia A Drug Sales, Revenue and Market Share by Country
8.1.1 South America Hemophilia A Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Hemophilia A Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Hemophilia A Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Hemophilia A Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Hemophilia A Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Hemophilia A Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Hemophilia A Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Hemophilia A Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Hemophilia A Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Hemophilia A Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Hemophilia A Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Hemophilia A Drug Sales and Market Share by Type (2015-2020)
10.2 Global Hemophilia A Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Hemophilia A Drug Price by Type (2015-2020)
11 Global Hemophilia A Drug Market Segment by Application
11.1 Global Hemophilia A Drug Sales Market Share by Application (2015-2020)
11.2 Global Hemophilia A Drug Revenue Market Share by Application (2015-2020)
11.3 Global Hemophilia A Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Hemophilia A Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Hemophilia A Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Hemophilia A Drug Market Forecast (2021-2025)
12.2.2 Europe Hemophilia A Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Hemophilia A Drug Market Forecast (2021-2025)
12.2.4 South America Hemophilia A Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Hemophilia A Drug Market Forecast (2021-2025)
12.3 Hemophilia A Drug Market Forecast by Type (2021-2025)
12.3.1 Global Hemophilia A Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Hemophilia A Drug Market Share Forecast by Type (2021-2025)
12.4 Hemophilia A Drug Market Forecast by Application (2021-2025)
12.4.1 Global Hemophilia A Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Hemophilia A Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Hemophilia A Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hemophilia A Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hemophilia A Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 8. Bayer AG Hemophilia A Drug Major Business
Table 9. Bayer AG Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 10. Bayer AG SWOT Analysis
Table 11. Bayer AG Hemophilia A Drug Product and Services
Table 12. Bayer AG Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Dimension Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 14. Dimension Therapeutics Inc Hemophilia A Drug Major Business
Table 15. Dimension Therapeutics Inc Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 16. Dimension Therapeutics Inc SWOT Analysis
Table 17. Dimension Therapeutics Inc Hemophilia A Drug Product and Services
Table 18. Dimension Therapeutics Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Catalyst Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 20. Catalyst Biosciences Inc Hemophilia A Drug Major Business
Table 21. Catalyst Biosciences Inc Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 22. Catalyst Biosciences Inc SWOT Analysis
Table 23. Catalyst Biosciences Inc Hemophilia A Drug Product and Services
Table 24. Catalyst Biosciences Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. BioMarin Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 26. BioMarin Pharmaceutical Inc Hemophilia A Drug Major Business
Table 27. BioMarin Pharmaceutical Inc Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 28. BioMarin Pharmaceutical Inc SWOT Analysis
Table 29. BioMarin Pharmaceutical Inc Hemophilia A Drug Product and Services
Table 30. BioMarin Pharmaceutical Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. DBV Technologies SA Basic Information, Manufacturing Base and Competitors
Table 32. DBV Technologies SA Hemophilia A Drug Major Business
Table 33. DBV Technologies SA Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 34. DBV Technologies SA SWOT Analysis
Table 35. DBV Technologies SA Hemophilia A Drug Product and Services
Table 36. DBV Technologies SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bioverativ Inc Basic Information, Manufacturing Base and Competitors
Table 38. Bioverativ Inc Hemophilia A Drug Major Business
Table 39. Bioverativ Inc Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 40. Bioverativ Inc SWOT Analysis
Table 41. Bioverativ Inc Hemophilia A Drug Product and Services
Table 42. Bioverativ Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Expression Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 44. Expression Therapeutics LLC Hemophilia A Drug Major Business
Table 45. Expression Therapeutics LLC Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 46. Expression Therapeutics LLC SWOT Analysis
Table 47. Expression Therapeutics LLC Hemophilia A Drug Product and Services
Table 48. Expression Therapeutics LLC Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 50. CSL Ltd Hemophilia A Drug Major Business
Table 51. CSL Ltd Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 52. CSL Ltd SWOT Analysis
Table 53. CSL Ltd Hemophilia A Drug Product and Services
Table 54. CSL Ltd Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Chugai Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table 56. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Major Business
Table 57. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 58. Chugai Pharmaceutical Co Ltd SWOT Analysis
Table 59. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product and Services
Table 60. Chugai Pharmaceutical Co Ltd Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. EpiVax Inc Basic Information, Manufacturing Base and Competitors
Table 62. EpiVax Inc Hemophilia A Drug Major Business
Table 63. EpiVax Inc Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 64. EpiVax Inc SWOT Analysis
Table 65. EpiVax Inc Hemophilia A Drug Product and Services
Table 66. EpiVax Inc Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. mAbxience SA Basic Information, Manufacturing Base and Competitors
Table 68. mAbxience SA Hemophilia A Drug Major Business
Table 69. mAbxience SA Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 70. mAbxience SA SWOT Analysis
Table 71. mAbxience SA Hemophilia A Drug Product and Services
Table 72. mAbxience SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Green Cross Corp Basic Information, Manufacturing Base and Competitors
Table 74. Green Cross Corp Hemophilia A Drug Major Business
Table 75. Green Cross Corp Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 76. Green Cross Corp SWOT Analysis
Table 77. Green Cross Corp Hemophilia A Drug Product and Services
Table 78. Green Cross Corp Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. LFB SA Basic Information, Manufacturing Base and Competitors
Table 80. LFB SA Hemophilia A Drug Major Business
Table 81. LFB SA Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 82. LFB SA SWOT Analysis
Table 83. LFB SA Hemophilia A Drug Product and Services
Table 84. LFB SA Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Idogen AB Basic Information, Manufacturing Base and Competitors
Table 86. Idogen AB Hemophilia A Drug Major Business
Table 87. Idogen AB Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 88. Idogen AB SWOT Analysis
Table 89. Idogen AB Hemophilia A Drug Product and Services
Table 90. Idogen AB Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Immusoft Corp Basic Information, Manufacturing Base and Competitors
Table 92. Immusoft Corp Hemophilia A Drug Major Business
Table 93. Immusoft Corp Hemophilia A Drug Total Revenue (USD Million) (2018-2019)
Table 94. Immusoft Corp SWOT Analysis
Table 95. Immusoft Corp Hemophilia A Drug Product and Services
Table 96. Immusoft Corp Hemophilia A Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Hemophilia A Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Hemophilia A Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Hemophilia A Drug Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Hemophilia A Drug Sales Market Share by Regions (2015-2020)
Table 101. Global Hemophilia A Drug Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Hemophilia A Drug Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Hemophilia A Drug Sales Market Share by Countries (2015-2020)
Table 104. North America Hemophilia A Drug Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Hemophilia A Drug Revenue Market Share by Countries (2015-2020)
Table 106. Europe Hemophilia A Drug Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Hemophilia A Drug Sales Market Share by Countries (2015-2020)
Table 108. Europe Hemophilia A Drug Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Hemophilia A Drug Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Hemophilia A Drug Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Hemophilia A Drug Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Hemophilia A Drug Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Hemophilia A Drug Sales Market Share by Countries (2015-2020)
Table 114. South America Hemophilia A Drug Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Hemophilia A Drug Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Hemophilia A Drug Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Hemophilia A Drug Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Hemophilia A Drug Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Hemophilia A Drug Revenue Market Share by Countries (2015-2020)
Table 120. Global Hemophilia A Drug Sales by Type (2015-2020) (K Pcs)
Table 121. Global Hemophilia A Drug Sales Share by Type (2015-2020)
Table 122. Global Hemophilia A Drug Revenue by Type (2015-2020) (USD Million)
Table 123. Global Hemophilia A Drug Revenue Share by Type (2015-2020)
Table 124. Global Hemophilia A Drug Sales by Application (2015-2020) (K Pcs)
Table 125. Global Hemophilia A Drug Sales Share by Application (2015-2020)
Table 126. Global Hemophilia A Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Hemophilia A Drug Market Share Forecast by Regions (2021-2025)
Table 128. Global Hemophilia A Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Hemophilia A Drug Market Share Forecast by Type (2021-2025)
Table 130. Global Hemophilia A Drug Sales Forecast by Application (2021-2025)
Table 131. Global Hemophilia A Drug Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Hemophilia A Drug Picture
Figure 2. Global Sales Market Share of Hemophilia A Drug by Type in 2019
Figure 3. ATXF-8117 Picture
Figure 4. BAY-1093884 Picture
Figure 5. BIVV-001 Picture
Figure 6. BS-027125 Picture
Figure 7. Concizumab Picture
Figure 8. CSL-689 Picture
Figure 9. Others Picture
Figure 10. Hemophilia A Drug Sales Market Share by Application in 2018
Figure 11. Clinic Picture
Figure 12. Hospital Picture
Figure 13. ASCs Picture
Figure 14. Global Hemophilia A Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Hemophilia A Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Hemophilia A Drug Sales Market Share by Manufacturer in 2019
Figure 35. Global Hemophilia A Drug Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Hemophilia A Drug Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Hemophilia A Drug Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Hemophilia A Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Hemophilia A Drug Revenue Market Share by Regions (2015-2020)
Figure 42. Global Hemophilia A Drug Revenue Market Share by Regions in 2018
Figure 43. North America Hemophilia A Drug Sales and Growth Rate (2015-2020)
Figure 44. Europe Hemophilia A Drug Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Hemophilia A Drug Sales and Growth Rate (2015-2020)
Figure 46. South America Hemophilia A Drug Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Hemophilia A Drug Sales and Growth Rate (2015-2020)
Figure 48. North America Hemophilia A Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Hemophilia A Drug Sales Market Share by Countries (2015-2020)
Figure 50. North America Hemophilia A Drug Sales Market Share by Countries in 2018
Figure 51. North America Hemophilia A Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Hemophilia A Drug Revenue Market Share by Countries in 2018
Figure 53. United States Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Hemophilia A Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Hemophilia A Drug Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Hemophilia A Drug Revenue Market Share by Countries in 2019
Figure 59. Germany Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Hemophilia A Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Hemophilia A Drug Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Hemophilia A Drug Revenue Market Share by Regions 2019
Figure 67. China Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Hemophilia A Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Hemophilia A Drug Sales Market Share by Countries in 2019
Figure 74. South America Hemophilia A Drug Revenue Market Share by Countries in 2019
Figure 75. Brazil Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Hemophilia A Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Hemophilia A Drug Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Hemophilia A Drug Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Hemophilia A Drug Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Hemophilia A Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Hemophilia A Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Hemophilia A Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Hemophilia A Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Hemophilia A Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Hemophilia A Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Hemophilia A Drug Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Hemophilia A Drug Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
甲状腺機能低下症治療の世界市場 2020年 Market Overview The global Hypothyroidism Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hypothyroidism Drug marke…- 小売用医薬品の世界市場 2020年 Market Overview The global Retail Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1350.1 million by 2025, from USD 1211 million in 2019. The Retail Drug market report …
- スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…
- アンカ血管炎薬の世界市場 2020年 Market Overview The global Anca Vasculitis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anca Vasculitis Drug mar…
- アンブリセンタン薬の世界市場 2020年 Market Overview The global Ambrisentan Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ambrisentan Drug market repo…